Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

Adamax Dosing Protocol: 5 mg Vial — Cognitive & Neurological Support Guide

Adamax peptide complex dosing guide — cognitive enhancement, vasopressin-like neuroprotective signaling, and memory consolidation support.

Go to peptide profileCalculate your dose

Quickstart highlights

Adamax is a proprietary peptide complex that, depending on the specific compounding pharmacy formulation, may contain vasopressin analogues, oxytocin-related peptides, or BPC-157/oxytocin combinations.

  • Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).
  • At 2 mg/mL: 2 mg = 100 units twice weekly.
  • Adamax composition varies by pharmacy — confirm active constituents before dosing.
  • Vasopressin V1b receptor activation: memory consolidation and social cognition enhancement.
  • One 5 mg vial provides 2.5 doses at 2 mg twice weekly — approximately 1.25 weeks per vial.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-4100050Twice weekly (Mon and Thu)1 mg — 50 units; starting dose; one 5 mg vial provides 5 doses at this level
5-122000100Twice weekly2 mg — 100 units; therapeutic dose; 2.5 doses per 5 mg vial

Your free Adamax tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Draw 2.5 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: 2 mg/mL. At 2 mg/mL: 1 mg = 50 units, 2 mg = 100 units.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

12-week plan

  • 6 vials
  • 24 syringes
  • 15 mL bac water
  • 24 alcohol swabs
Need clinics? See vetted providers →
Advertisement

Protocol overview & cycle notes

Support memory consolidation, neuroprotective vasopressin receptor signaling, and cognitive clarity through twice-weekly Adamax subcutaneous injections over a 12-week protocol.

Cycle length: 12 weeks on.

Off-cycle: 4–8 weeks off after 12-week protocol.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 28 days.

Injection & tracking tips

  • Inject subcutaneously (abdomen or thigh) twice weekly; maintain consistent injection-day schedule for even pharmacodynamic coverage.
  • Adamax compounds vary by source — confirm peptide composition (active constituents) from your compounding pharmacy before establishing dosing.
  • Cognitive enhancement effects, if present, are typically reported within 2–4 weeks of twice-weekly dosing.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Track cognitive performance weekly (digit span test, reaction time app).
  • Log mood, motivation, and social behavior (0–10) on injection days and off-days.
  • Monitor blood pressure — vasopressin-like peptides may cause transient BP elevation at higher doses.
Log your cycle in the calculator →

How this works & references

Adamax is a proprietary peptide complex that, depending on the specific compounding pharmacy formulation, may contain vasopressin analogues, oxytocin-related peptides, or BPC-157/oxytocin combinations. Vasopressin (ADH, arginine vasopressin) acts centrally via V1b receptors in the hippocampus and amygdala, enhancing memory consolidation and social cognition. DDAVP (desmopressin, synthetic AVP analogue) has documented memory-enhancing effects in healthy volunteers and amnesia patients. When Adamax contains a vasopressin-like component, memory consolidation enhancement is the primary expected mechanism.

Sources

  • Source: Koob GF, Bloom FE — Vasopressin and memory consolidation. Science. 1982;216:890-2
  • Source: Bruins J et al. — DDAVP improves memory in healthy volunteers: double-blind cross-over trial. Psychopharmacology. 1992

Frequently asked questions

What exactly is Adamax?
Adamax is a proprietary peptide name used by various compounding pharmacies, which may refer to different formulations: (1) An oxytocin + BPC-157 blend; (2) A vasopressin analogue (AVP/DDAVP-like compound); (3) A proprietary nootropic peptide complex. Confirm the exact active constituents with your compounding pharmacy before establishing dosing parameters.
How does vasopressin enhance memory?
Vasopressin (AVP) acts on hippocampal V1b receptors, facilitating synaptic consolidation of short-term memories into long-term storage. Koob and Bloom (1982) demonstrated that vasopressin facilitates memory consolidation in rodent models and human studies. DDAVP nasal spray significantly improved word recall in healthy volunteers (Bruins et al., 1992). The effect is most pronounced for emotionally significant or effortful learning.
Can Adamax cause water retention or hyponatremia?
If Adamax contains a vasopressin analogue with antidiuretic (V2 receptor) activity: yes, water retention and dilutional hyponatremia are risks with excess fluid intake. Pure V1b agonists (hypothalamic) do not produce antidiuretic effects. Confirm receptor selectivity of your specific Adamax formulation. With standard compounding doses and normal fluid intake, hyponatremia risk is low.
Is Adamax the same as DDAVP?
DDAVP (desmopressin) is an FDA-approved synthetic vasopressin analogue specifically designed for antidiuretic effects (primary nocturnal enuresis, central diabetes insipidus). Adamax, if vasopressin-like, may have a different receptor selectivity profile than DDAVP — specifically potentially more V1b (cognitive) versus V2 (antidiuretic) activity. They are not interchangeable without knowing the exact peptide structure.
Who should consider Adamax?
Adamax may be relevant for: (1) Individuals seeking memory consolidation support (students, executives, aging adults); (2) Post-traumatic amnesia recovery; (3) Brain fog from stress or hormonal dysregulation; (4) Social cognition enhancement for oxytocin-containing formulations. Given formulation variability, individual assessment with a physician knowledgeable in peptide medicine is essential.

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

View protocol

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

View protocol

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →